This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
ai-and-machine-learning 
Fierce Pharma
DECEMBER 20, 2022
2023 forecast: An 'inflection point' for biopharma, fueled by a flood of AI and machine learning products. Tue, 12/20/2022 - 13:39.
247 247 
Fierce Pharma
MARCH 9, 2023
The Top Line': Why pharma needs to ramp up its use of AI and machine learning, plus this week's headlines tcarey Thu, 03/09/2023 - 15:25
232 232 This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
FEBRUARY 5, 2024
Since the public debut of OpenAI’s GPT-4 little over a year ago, artificial intelligence (AI) and machine learning (ML) have been the subject of endless, and often breathless, media coverage and analysis — a source of both anxiety and elation over their potential to transform the way we live and work.
52 
PharmaTech
MAY 24, 2023
As organizations seek to identify areas where technology can make the most impact, a look at some real-world examples of how artificial intelligence (AI) and machine learning (ML) are being used in highly regulated environments can offer valuable insight.
52 
PharmExec
DECEMBER 22, 2023
Oxford Academic report explores the positive improvements these technological capabilities could bring to the industry.
126 
Copyright Clearance Center
OCTOBER 2, 2023
This is our AI Daily Roundup. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities
52 
MedCity News
FEBRUARY 12, 2024
By leveraging AI and machine learning, researchers can analyze complex data sets, identify novel biomarkers, and provide more effective and tailored treatment options for cancer patients.
109 
PharmExec
OCTOBER 4, 2022
October 4th 2022 9 am CT |10 am ET | 3 pm BST | 4 pm CET Managing drug, vaccine, and device safety has become increasingly challenging as companies are confronted with adverse event (AE) caseloads rising as much as 30-50% per year.
52 
PharmaTech
OCTOBER 11, 2023
The new Digital Health Advisory Committee will advise the agency on issues related to technologies such as AI, virtual reality, and machine learning.
116 116 
European Pharmaceutical Review
JANUARY 24, 2024
The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8
126 
European Pharmaceutical Review
JANUARY 9, 2024
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.
European Pharmaceutical Review
OCTOBER 25, 2023
Three key medicine regulatory bodies from the UK, US and Canada have collaborated to publish five guiding principles for machine learning-enabled medical devices MLMDs. The aim is to remove the regulatory burden of reassessment following certain changes and updates to a medical device by a manufacturer.
90 
Clarivate
JUNE 29, 2023
There are, however, some truly alluring potential use cases for generative AI applications such as ChatGPT for the life sciences and healthcare industries – as well as some pressing limitations. At Clarivate, we have been a longtime trailblazer in the implementation of AI to enhance our tools and solutions.
98 
European Pharmaceutical Review
SEPTEMBER 29, 2023
A paper published in the IEEE Sensors Journal has demonstrated 100 percent inline pharmaceutical packaging content verification by combining standard diffuse reflectance MOEMS-EC-QCL spectroscopy with artificial intelligence (AI). Automatic detection and classification of a number of pills was achieved in the study. In comparison, only 97.4
MedCity News
APRIL 19, 2023
Automation, AI, and machine learning can all be used to identify issues that lead to denials, streamline the patient billing process, reduce manual processes, and provide real-time data to quickly process claims.
European Pharmaceutical Review
JUNE 16, 2023
According to a recent review funded by GSK Biologicals, artificial intelligence (AI) and machine learning (ML) seems intuitively, to be well suited to perform pharmacovigilance (PV) tasks given the large volume of data, high degree of uncertainty and need to learn from data. Bate et al.
89 
PharmaVoice
JANUARY 16, 2024
FDA Commissioner Dr. Robert Califf recently spoke about the future of AI and machine learning and the need for constant vigilance to improve healthcare systems.
59 
Clarivate
APRIL 15, 2024
Artificial intelligence (AI) is evolving rapidly with new business use cases constantly emerging. Our research found that IP professionals are currently grappling with what AI could mean for them, their practice and their processes. Key questions for the sector to ask include: What does AI mean for IP law and practice?
59 
PM360
OCTOBER 25, 2023
Everyone’s buzzing about generative artificial intelligence (AI), and it’s true that technology like ChatGPT is already having an enormous impact on advertising and marketing. But other AI tools that our industry has been using for years have changed the face of media planning and buying. What is genetic AI?
115 
MedCity News
APRIL 25, 2023
However, the time to begin investing in – and exploring – AI, machine learning, and big data is now. Traditionally, pharmaceutical companies have been slow to adopt these newer technologies, instead relying on well-established and proven – but usually complex – manufacturing processes.
95 
Clarivate
MAY 22, 2023
From self-driving cars to ChatGPT and Amazon Bedrock, the world is quickly waking up to the enormous potential for artificial intelligence (AI) to change our world. We use generative AI to ensure we provide our customers with the highest quality integrated public and proprietary content and insights, whilst also mitigating any risks involved.
115 
MedCity News
MAY 26, 2023
A conversation with Suchi Saria, associate professor of medicine at John Hopkins University and director of its Machine Learning and Healthcare Lab about responsible AI.
79 
MedCity News
MAY 31, 2023
A recent webinar sponsored by DexCare explored how the consumerization trend is shifting expectations for health consumers and how companies are enlisting AI tools such as machine learning and Chat GPT to improve the patient experience. Register to access the recording.
86 
Medical Device Success
MARCH 13, 2022
To help us look at AI in radiology and MedTech is Paul Yi, MD, Director, University of Maryland Medical Intelligent Imaging Center. As usual, this is an information packed episode that will position you to better understand AI and how it can contribute to your future and your company’s future. More housekeeping.
130 
PharmaTech
DECEMBER 8, 2023
MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.
52 
MedCity News
OCTOBER 6, 2022
Northwell recently invested $3 million in Hume AI, an expressive communication research lab and AI startup. The health system is partnering with Hume to develop machine learning models designed to better understand patients’ vocal and nonverbal communications.
81 81 
European Pharmaceutical Review
MAY 11, 2023
The US Food and Drug Administration (FDA) has released a discussion paper to complement and inform future guidance on artificial intelligence (AI) and machine learning (ML) in drug development. The paper also highlighted that AI/ML can enhance manufacturing supply chain.
European Pharmaceutical Review
JANUARY 12, 2024
A recent survey from the Pistoia Alliance revealed that AI and machine learning (ML) will be the top technology investment for 60 percent of life sciences companies over the next two years. Levy is a leading life sciences expert who has published multiple articles on drug development and technology trends.
78 
Medical Device Success
APRIL 3, 2022
Our guest today says that even though EHRs were not intentionally designed to aid clinical informatics “without EHR we would have no AI in healthcare.”. This is our 6 th episode related to AI in MedTech. This is our 6 th episode related to AI in MedTech. Reading time: 4 – 6 minutes. EHR is actually more powerful than EMR.
130 
LEVO Health
DECEMBER 28, 2023
VR Videos for Medical Training and Demonstrations VR videos in medical training and demonstrations have been a game-changer, enabling HCPs to simulate procedures and provide hands-on learning experiences. This approach tailors the viewing experience to individual patients, considering their unique needs, preferences, and behaviors.
52 
Copyright Clearance Center
OCTOBER 10, 2023
The solution combines sophisticated, AI-enabled, affiliation-matching technology and analytic capabilities, to reliably disambiguate institution affiliation and funder relationships. This empowers publishers to easily structure and negotiate OA agreements. CCC is an active partner in the evolution of OA publishing models.
118 
Pharmaceutical Technology
NOVEMBER 25, 2022
Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’.
145 
Pharmacy Times
APRIL 3, 2024
is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene's core expertise in synthesizing and testing the molecules in vitro and in vivo. Aurigene.AI
Contrarian Sales Techniques
MAY 17, 2024
When I first entered the field of medical sales, the idea of artificial intelligence (AI) playing a role in our work seemed like science fiction. My first encounter with AI in medical sales was about five years ago. According to the AI system, Dr. Patel had shown interest in recent studies about a new treatment option we were offering.
MedCity News
JANUARY 30, 2024
Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. Cancer treatment is one area that could benefit significantly from AI, as it can aid in early detection, precise diagnosis, and personalized treatment plans. Now, we can. for human radiologists.
121 
Medgadget
FEBRUARY 7, 2023
The postage stamp-sized patch can be worn on the skin of the chest and uses AI and ultrasound waves to perform advanced imaging of the heart. We use this machine learning model to calculate the heart volume based on the shape and area of the left ventricle segmentation. “We
129 
Nixon Gwilt Law
NOVEMBER 16, 2023
How hot is generative AI in healthcare innovation right now? Some say you could add “AI'' to your digital health startup’s name and double your funding goal before the week is out. While that might be a slight exaggeration, you can confidently bet that generative AI will revolutionize healthcare—and it won’t take long.
52 
MedCity News
SEPTEMBER 20, 2023
In the realm of pharmaceuticals, where innovation can be the difference between life and death, the emergence of generative AI, has been nothing short of transformative. Generative AI, powered by advanced machine learning algorithms, is rapidly reshaping the landscape of drug discovery, development, and optimization.
99 
pharmaphorum
NOVEMBER 23, 2022
Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South Coast back in October, pharmaphorum had a chance to drop by the booth of EY and discuss not only its consulting operations, but the company’s Smart Reviewer, and their own assessment of the industry event itself. It’s been quite busy.
96 
Medgadget
JULY 19, 2023
The team used machine learning to train the gloves on a simple tune, and then when users play the tune the gloves can provide feedback on where they went wrong. The system uses AI to inform a training component. So far, the researchers have focused on using the gloves to assist patients to play music.
68 
European Pharmaceutical Review
NOVEMBER 1, 2022
Researchers from Qingdao University of Science and Technology, China have used artificial intelligence (AI) to predict compounds that could neutralise baldness-causing reactive oxygen species in the scalp. The post Microneedle patches designed by AI restore hair in balding mice appeared first on European Pharmaceutical Review.
Pharmaceutical Technology
FEBRUARY 17, 2023
Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. It will use the machine learning platform from Zephyr AI and a real-world data set (RWD) from M2GEN for creating an oncology discovery product.
59 
European Pharmaceutical Review
SEPTEMBER 12, 2023
Initial data from the CPHI Annual Report 2023, which provides insight from 250 global pharmaceutical companies, reveals that AI (artificial intelligence) is expected to transform every area of the industry, from drug discovery through to drug development , within the next 24-months.
PM360
APRIL 22, 2024
The evolution of risk-based quality management (RBQM), wider adoption of artificial intelligence (AI) and regulatory updates have set the scene for a new holistic approach to data management. In the future, generative AI could be used to simulate control groups, or “synthetic arms”. Now we need the people power. Clinical Research 2.0
52
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content